Sculptor Capital LP Merck & Co., Inc. Transaction History

Sculptor Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $32.1 Million - $36.4 Million	-384,335 Reduced 80.98%	90,277 $8.23 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $16 Million - $18 Million	218,208 Added 85.1%	474,612 $38.9 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $32.2 Million - $40.3 Million	-445,473 Reduced 63.47%	256,404 $19.7 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $48.8 Million - $55.7 Million	701,877 New	701,877 $0

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.